The endotherapy devices market has seen considerable growth due to a variety of factors.
•In recent times, there has been robust growth in the endotherapy devices market size. Projected growth from $4.63 billion in 2024 to $4.91 billion in 2025, this market is anticipated to experience a compound annual growth rate (CAGR) of 6.0%.
The historical growth can be attributed to factors like an increase in gastrointestinal disorders, an advancing age population, improvements in diagnosis due to heightened awareness, beneficial reimbursement policies, the development of the global economy, and strategic collaborations and partnerships.
The endotherapy devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust expansion in the endotherapy devices market in the upcoming years. The anticipated growth projection is set to reach $6.64 billion in 2029 with a compound annual growth rate (CAGR) of 7.9%.
The growth predicted for this forecast period is attributable to developments in minimally invasive procedures, the rising impact of chronic illnesses, the augmentation of healthcare infrastructures, a heightened emphasis on early detection, regulatory backing, and standardization. The forecast period is also expected to witness major trends such as advancements in imaging technologies, the inclusion of artificial intelligence, technological evolution, the worldwide enlargement of healthcare infrastructure, and the escalating prevalence of gastrointestinal conditions.
Gain Insights Into The Endotherapy Devices Global Market Report 2025 With A Free Sample Report Here:
The upswing in gastrointestinal disease occurrence is anticipated to stimulate the growth of the endotherapy devices market. Diseases affecting the digestive tract - from the mouth to the anus - like colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), Crohn's disease (CD), and more, are considered gastrointestinal illnesses. They are managed using endotherapy devices to conduct non-invasive or slightly invasive surgical interventions for the treatment and diagnosis of ulcers, hemorrhages, celiac disease, blockages, inflammation, and tumors in the gastrointestinal tract. Further, these devices assist in locating the cause of undiagnosed symptoms such as heartburn, stomach discomfort, bleeding, nausea, emesis, and pain. For instance, Cancer Australia - an Australian organization - reported in January 2024 that Australia is predicted to witness 2,576 new cases of stomach cancer in 2023, including 1,647 in men and 929 in women. The estimated risk of diagnosis by the age of 85 is roughly 1 in 117 (0.85%), with a higher rate in males (1 in 91, or 1.1%), and lower in females (1 in 164, or 0.61%). Thus, the surge in the prevalence of gastrointestinal diseases is a key driver for the expansion of the endotherapy devices market.
The endotherapy devices market covered in this report is segmented –
1) By Product: Gastrointestinal Devices and Accessories, Endoscopic Retrograde Cholangio Pancreatography Devices And Accessories, Other Endotherapy Devices
2) By Application: Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuro-Endoscopy, Gastrointestinal Endoscopy, Other Applications
3) By End-Use: Hospital, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Gastrointestinal Devices And Accessories: Endoscopic Mucosal Resection (EMR) Devices, Endoscopic Submucosal Dissection (ESD) Devices, Biopsy Forceps, Clips And Closure Devices, Electrosurgical Devices
2) By Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices And Accessories: ERCP Cannulas, Balloon Sweep Devices, Stents, Guidewires, Sphincterotomes
3) By Other Endotherapy Devices: Endoscopic Ultrasound (EUS) Devices, Ablation Devices, Foreign Body Retrieval Devices, Laser Therapy Devices
Key players in the endotherapy devices sector are innovating with advanced solutions such as red dichromatic imaging (RDI), which improves the observation of blood vessels and bleeding points during endoscopic procedures. RDI in endotherapy devices increases the visibility of blood vessels and lesions using two distinct wavelengths of light, thereby upping the accuracy of diagnoses during procedures. Taking as an example, Olympus Corporation, a medical technology firm based in Japan, introduced an endoscopy system known as EVIS X1 in October 2023. Renowned for housing cutting-edge imaging technologies and artificial intelligence, the EVIS X1 augments both visualization and diagnostic competencies. This state-of-the-art endoscopy system not only improves diagnostic capabilities through its sophisticated imaging technologies, but also uses texture and color enhancement imaging (TXI) to boost the visibility of lesions and polyps by enriching color and texture. Its red dichromatic imaging (RDI) emphasizes deep blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) ensures balance in brightness across the image.
Major companies operating in the endotherapy devices market include:
• Olympus Corporation
• Boston Scientific Corporation
• Conmed Corporation
• Medtronic Plc
• Fujifilm Holdings Corporation
• Johnson & JohnsonCook Group Incorporated
• Karl Storz SE & Co. KG
• Stryker Corporation
• Taewoong Medical Co. Ltd
• Smith & Nephew Plc.
• Steris Corporation
• Micro-Tech (Nanjing) Co Ltd.
• HOYA Corporation
• Cook Group Incorporated
• B. Braun Melsungen AG
• Frontier Healthcare
• Pentax Medical
• Nipro Corporation
• MEDIVATORS B.V.
• US Endoscopy Group Inc.
• Richard Wolf GmbH
• Cantel Medical Corp.
• Fujinon Corporation
• Gyrus ACMI
• Cogentix Medical Inc.
• Endogastric Solutions Inc.
North America as the largest region in the endotherapy devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa